UFT Plus Cisplatin With Concurrent Radiotherapy for Locally Advanced Non–Small-Cell Lung Cancer
ByYukito Ichinose, MD,Tokujiro Yano, MD,Hiroshi Asoh, MD,Hideki Yokoyama, MD,Riichiroh Maruyama, MD,Chie Ushijima, MD,Tadashi Uehara, MD,Takanori Kanematsu, MD,Tomofumi Yohena, MD,Susumu Wada, MD
Published: | Updated:
A phase II study of combined-modality treatment consisting of uracil and tegafur (in a molar ratio of 4:1 [UFT]) plus cisplatin (Platinol) and concurrent radiotherapy was conducted to evaluate the activity of this regimen in